1Jun Zhou,D.C. Allred,Ingalill Avis,Alfredo Martínez,Michele D. Vos,Leia Smith,Anthony M. Treston,James L. Mulshine. Differential Expression of the Early Lung Cancer Detection Marker, Heterogeneous Nuclear Ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in Normal Breast and Neoplastic Breast Cancer[J] 2001,Breast Cancer Research and Treatment(3):217～224
2Cerwenka R, Haigner R, Bacher H, et al. TU M2 PK(phruvatekinase type tumor M2) CA19 -9 and CEA in patients with malignant and metastasizing nanceratic cancer. Anti Cancer Res, 1999,19 ( 1 ) :849.
3Velculesc,a VE, Madden SL, Zhang L, et al. Analysis of human transcnptomes. Nat Genet, 1999,23:387.
4Monzo M, Rosell R, Felip E, et al. A novel anti -apoptosis gene: re - expressien of surivin mesenger RNA as a prognosis marker in non - small - cell lung cancers. J Clin Oncol, 1999,17 (2) : 100.
5Wloch M, et al. Expression of early lung cancer detection marker HnRNP A2/B1 and its relation to rnicrosatellite alterafionin non small cell lung cancer. Lung Cancer, 2001, 34(3) :341.
6Rohayem J, Dieste L, Koetter P, et al. Antibody response to the tumor associated inhibitor of apoptosis protein survivin in cancer patients. Cancer Res,2000,60(7) :1815.
7Sarela R, Falleni M, Pellegrini C, et al. Survivin gene expression in early-stage non- small cell lung cancer. J Pathol, 2003,200(5) :620.
8Tanaka C ,Wright GS, Gruidl ME. Early detection an prevention of lung cancer. Curr Opin Oncol, 2000,12(2) :143.
